IL1B and breast cancer: (168) cisplatin- or adriamycin/cyclophosphamide-related chemotherapy used to treat breast cancer metastasis to the lungs induced NLRP3-associated IL-1β secretion by tumor cells, which induced neutrophil recruitment and NETs formation, resulting in a reduced response to therapy in the mice tested.